Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Kraken Zone Discovery Unlocks Significant Value (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Perspective Therapeutics Inc CATX

Healthcare Medical Devices
Perspective Therapeutics, Inc., together with its subsidiaries, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. The company discovers, and develop its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSEAM:CATX)

Perspective Therapeutics to Provide Business Highlights and Report Full Year 2025 Financial Results

GlobeNewswire February 17, 2026

Perspective Therapeutics Announces Pricing of $175 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire February 2, 2026

Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 12, 2026

Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial at the 2026 ASCO Gastrointestinal Cancers Symposium

GlobeNewswire January 9, 2026

Perspective Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 18, 2025

Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the ASCO Gastrointestinal Cancers Symposium

GlobeNewswire December 4, 2025

Perspective Therapeutics to Participate in Upcoming December Conferences

GlobeNewswire November 20, 2025

Perspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2025 Results

GlobeNewswire November 10, 2025

Perspective Therapeutics to Participate in Upcoming November Conferences

GlobeNewswire October 31, 2025
View More News ››

Opinion & Analysis (NYSEAM:CATX)

U.S. Biotech Rolls Out New Brachytherapy Delivery Tool Used for Prostate Cancer

Streetwise Reports October 1, 2019

Company with Cancer Radiotherapy Grows Revenue for Six Consecutive Quarters

Streetwise Reports October 4, 2018

Coverage Initiated on Developer of Brachytherapy Products for Cancer Treatment

Streetwise Reports August 22, 2018

Medical device firm boosts quarterly revenue 50% YOY

Streetwise Reports January 31, 2018
View More Opinion ››

Bullboard Posts (NYSEAM:CATX)

RE:Perspective Therapeutics to Pursue Dose Escalation of [212Pb

Alot of News
SuperTrader1970 - April 10, 2025

CATX.....Yowser....huge volume increase to move it

to H.O.D Ya just never know Dang 2x's Dang !!!!!
Iseneschal - September 18, 2023

CATX....dang !!!!!!

It popped
Iseneschal - September 18, 2023

CATX....no chasing for me

No position
Iseneschal - September 18, 2023

CATX.....running and on Watch list

42 pesos
Iseneschal - September 18, 2023

world need this!

considering the options of orafice's, a winner!
north40 - January 16, 2021
View more Bullboard ››

Kobrea Exploration Corp.

Kobrea Exploration Corp.

Kobrea Exploration Corp. engages in the acquisition, exploration, and evaluation of mineral properties in Canada. It holds a ...
View More »

Podcasts